It suggests that carvacrol blocks TRPM7 function partly by reducing its enzyme substrate, m-calpain, to restore Bcl-2 expression leading to prevention of apoptosis in neonatal hypoxic-ischemic brain injury. Here, CAPN2 is linked to brain injury.